Clinical Trial Update: Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating adding venetoclax to high-dose chemotherapy before a mismatched allogeneic stem cell transplant for acute myeloid leukemia and myelod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: Northside Hospital, Inc. | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: WITHDRAWN